Xtant Medical Holdings, Inc. (XTNT) Stock Price

XTNTStock

$0.38−39.05%52W

Market Cap$53.87M

P/E8.75x

PEG Ratio1.74

Div yield—

Beta-0.24

XTNT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-44.57%

Price vs S&P 500 (4W)-14.27%

PEG Ratio1.74

VGM Score61.09

P/E Ratio (Annual)8.75x

P/CF (Annual)3.47x

Book Value / Share (Quarterly)$0.35

P/TBV (Annual)2.17x

Revenue Growth (3Y)32.20%

Cash Flow / Share (Quarterly)$0.06

Price vs S&P 500 (YTD)-63.84%

Gross Margin (TTM)62.34%

Net Profit Margin (TTM)1.50%

EPS (TTM)$0.01

10-Day Avg Trading Volume8.56M

EPS Excl Extra (TTM)$0.01

Revenue Growth (5Y)20.22%

EPS (Annual)$0.03

ROI (Annual)6.51%

Gross Margin (Annual)62.92%

Net Profit Margin (5Y Avg)-6.60%

Cash / Share (Quarterly)$0.09

P/E Basic Excl Extra (TTM)23.84x

Revenue Growth QoQ (YoY)-36.53%

P/E Normalized (Annual)8.75x

ROA (Last FY)5.28%

Revenue Growth TTM (YoY)-0.32%

EBITD / Share (TTM)$0.08

ROE (5Y Avg)-13.55%

Operating Margin (TTM)5.40%

Cash Flow / Share (Annual)$0.07

P/B Ratio0.90x

P/B Ratio (Quarterly)1.61x

Net Income / Employee (Annual)$32,900

EV / Revenue (TTM)0.36x

Net Interest Coverage (TTM)2.92x

ROA (TTM)1.91%

EV / EBITDA (TTM)3.88x

EPS Incl Extra (Annual)$0.03

Current Ratio (Annual)2.65x

Quick Ratio (Quarterly)1.56x

3-Month Avg Trading Volume1.07M

52-Week Price Return-39.05%

EV / Free Cash Flow (Annual)4.30x

P/E Incl Extra (TTM)23.84x

Revenue / Employee (TTM)$807,300

Tangible BV / Share (Quarterly)$0.34

P/S Ratio (Annual)0.33x

Asset Turnover (Annual)1.42x

52-Week High$0.95

Operating Margin (5Y Avg)-3.87%

EPS Excl Extra (Annual)$0.03

CapEx CAGR (5Y)9.04%

Tangible BV CAGR (5Y)29.22%

26-Week Price Return-32.64%

Quick Ratio (Annual)1.55x

13-Week Price Return-18.30%

Total Debt / Equity (Annual)0.50x

Current Ratio (Quarterly)3.34x

Enterprise Value$43.69M

Revenue / Share Growth (5Y)-13.76%

Asset Turnover (TTM)1.28x

Book Value / Share Growth (5Y)14.22%

Revenue / Employee (Annual)$886,900

Inventory Turnover (Annual)1.44x

Pretax Margin (Annual)5.23%

Cash / Share (Annual)$0.12

3-Month Return Std Dev78.05%

Gross Margin (5Y Avg)59.21%

Net Income / Employee (TTM)$12,100

EBITDA CAGR (5Y)64.07%

EBITDA Interim CAGR (5Y)45.07%

ROE (Last FY)9.76%

Net Interest Coverage (Annual)2.30x

EPS Basic Excl Extra (Annual)$0.03

P/FCF (TTM)4.28x

Receivables Turnover (TTM)6.00x

EV / Free Cash Flow (TTM)5.62x

Total Debt / Equity (Quarterly)0.25x

EPS Incl Extra (TTM)$0.01

Receivables Turnover (Annual)6.96x

ROI (TTM)2.44%

P/S Ratio (TTM)0.36x

Pretax Margin (5Y Avg)-6.61%

Revenue / Share (Annual)$0.89

Tangible BV / Share (Annual)$0.36

Forward P/E45.04x

Price vs S&P 500 (52W)-57.61%

P/E Ratio (TTM)23.84x

Year-to-Date Return-51.02%

5-Day Price Return18.96%

EPS Normalized (Annual)$0.03

ROA (5Y Avg)-6.90%

Net Profit Margin (Annual)3.71%

Month-to-Date Return-10.66%

Cash Flow / Share (TTM)$0.05

EBITD / Share (Annual)$0.11

Operating Margin (Annual)7.89%

LT Debt / Equity (Annual)0.22x

P/CF (TTM)4.76x

ROI (5Y Avg)-8.27%

P/E Excl Extra (TTM)23.84x

LT Debt / Equity (Quarterly)0.17x

EPS Basic Excl Extra (TTM)$0.01

P/TBV (Quarterly)1.62x

P/B Ratio (Annual)2.15x

Inventory Turnover (TTM)1.30x

Pretax Margin (TTM)3.20%

Book Value / Share (Annual)$0.36

Price vs S&P 500 (13W)-20.25%

Beta-0.24x

P/FCF (Annual)4.28x

Revenue / Share (TTM)$0.87

ROE (TTM)3.68%

52-Week Low$0.27

vGradeA

gGradeC

mGradeC

vgmGradeB

XTNT Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 11, 2026	-$0.02	-$0.03	-35.50%(-$0.01)
Q1 2026	May 13, 2026	-$0.02	-$0.02	+9.80%(+$0.00)
Q4 2025	Mar 31, 2026	$0.00	-$0.01	+0.00%(-$0.01)
Q3 2025	Nov 10, 2025	-$0.01	$0.01	+300.00%(+$0.02)
Q2 2025	Aug 12, 2025	-$0.02	$0.03	+248.50%(+$0.05)

XTNT Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.22

4.13

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
XTNTXtant Medical Holdings, Inc.	A	C	C	$0.38
SYKStryker Corporation	C	B	C	$330.69
MMM3M Company	C	D	C	$174.34
BSXBoston Scientific Corp.	C	B	D	$46.84
BDXBecton, Dickinson and Co.	B	D	B	$189.52
MDLNMedline Inc. Class A common stock	C	D	C	$35.28
RMDResMed Inc.	C	B	B	$240.33
DXCMDexCom, Inc.	D	B	B	$90.82
WSTWest Pharmaceutical Services, Inc.	D	C	B	$337.47
SOLVSolventum Corporation	C	C	B	$91.12
BAXBaxter International Inc.	B	D	B	$26.13
PENPenumbra, Inc.	D	C	C	$321.68
GMEDGLOBUS MEDICAL INC	B	B	C	$82.97
GKOSGlaukos Corporation	F	A	A	$179.87
PODDInsulet Corporation	C	A	C	$145.13
TFXTeleflex Incorporated	B	F	B	$139.67
STVNStevanato Group S.p.A.	D	C	C	$21.03
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$20.10
MMSIMerit Medical Systems Inc	C	B	B	$90.49
HAEHaemonetics Corporation	C	C	A	$103.96
ICUIICU Medical Inc	C	D	B	$175.10
HTFLHeartflow, Inc. Common Stock	—	A	B	$47.78
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$120.25
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$47.57
ATRCAtriCure, Inc.	D	B	B	$48.54
UFPTUFP Technologies Inc	C	B	B	$300.05
NVCRNovoCure Limited Ordinary Shares	D	C	B	$17.82
LMATLeMaitre Vascular, Inc.	C	B	C	$80.45
INSPInspire Medical Systems, Inc.	B	B	B	$61.44
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$25.64
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.43
ATECAlphatec Holdings, Inc.	D	B	C	$9.44
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.64
IARTIntegra LifeSciences Holdings	B	D	B	$16.89
AORTArtivion, Inc.	C	C	C	$26.77
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$20.83
IRMDiRadimed Corporation	D	B	C	$87.07
BVSBioventus Inc. Class A Common Stock	B	C	A	$13.84
BBNXBeta Bionics, Inc. Common Stock	D	A	B	$19.72
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.42
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.21
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.48
MDXGMiMedx Group, Inc	C	D	C	$4.50
ANGOAngioDynamics, Inc.	C	D	A	$15.85
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$23.65
BWAYBrainsway Ltd. American Depositary Shares	F	A	B	$14.30
DCTHDelcath Systems Inc	D	B	A	$16.34
CERSCerus Corp	D	C	B	$2.65
TCMDTactile Systems Technology, Inc.	B	B	C	$23.16
NPCENeuropace, Inc. Common Stock	D	C	B	$14.41
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$15.55

About Xtant Medical Holdings, Inc.

Xtant Medical Holdings develops and commercializes orthobiologics and spinal implant systems for complex spinal fusion, deformity, and degenerative procedures. Its product portfolio includes OsteoSponge, OsteoSelect Plus, OsteoWrap, and 3Demin allografts, sold to orthopedic spine surgeons and neurosurgeons. The company generates the majority of its revenue from the U.S. market.